AKI India Board of Directors
Get the latest insights into the leadership at AKI India. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Mohammad Ajwad | Managing Director |
| Mrs. Sameena Asad Iraqi | Whole Time Director |
| Mr. Mohammad Asjad | Non Executive Director |
| Mr. Raj Krishna Agrawal | Independent Director |
| Mr. Aslam Saeed | Independent Director |
| Mr. Javed Iqbal | Independent Director |
AKI India Share price
AKI
9.13
0.22 (-2.35%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:45 IST
BUYSELL
Today's High
9.70
Today's Low
9.00
52 Week Low
6.63
52 Week High
22.47
The current prices are delayed, login to your account for live prices
LoginAKI India FAQs
The board at AKI India consists of experienced professionals, including Mr. Mohammad Ajwad , Mrs. Sameena Asad Iraqi , and others, overseeing the company’s strategic and corporate governance.
Directors at AKI India are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Mohammad Ajwad is the current chairman at AKI India.
Executive directors at AKI India are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, AKI India adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At AKI India, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.